O Schroder
Overview
Explore the profile of O Schroder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stratmann K, Bock H, Filmann N, Fister P, Weber C, Tacke W, et al.
United European Gastroenterol J
. 2018 Sep;
6(7):1082-1088.
PMID: 30228897
Background: Colorectal cancer (CRC) is the second most common cancer in Germany. Screening colonoscopies are considered an effective tool for early detection and prevention of CRC and are recommended in...
2.
Blumenstein I, Tacke W, Filmann N, Zosel C, Bock H, Heuzeroth V, et al.
Z Gastroenterol
. 2013 May;
51(7):613-8.
PMID: 23696113
Introduction: In our previous studies investigating the drug therapy in patients suffering from inflammatory bowel disease (IBD) in the Rhein-Main region, Germany, we detected serious discrepancies between treatment reality and...
3.
Oestern S, Varoga D, Trompetter R, Lippross S, Kluter T, Weuster M, et al.
Unfallchirurg
. 2013 Mar;
116(3):255-68.
PMID: 23478901
Knee joint infection represents an emergency case at every age. Joint infection occurs frequently after trauma or joint surgery. The infection can be caused by numerous bacteria, viruses, or yeasts;...
4.
Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, et al.
J Crohns Colitis
. 2011 May;
5(3):203-10.
PMID: 21575882
Background: The introduction of immunosuppressants and biologic agents has led to active debate and research about optimal therapeutic strategies considering risk factors and predictors of clinical outcome in inflammatory bowel...
5.
Rogers J, Schoepp R, Schroder O, Clements T, Holland T, Li J, et al.
Protein Eng Des Sel
. 2008 May;
21(8):495-505.
PMID: 18480090
Using a comprehensive set of discovery and optimization tools, antibodies were produced with the ability to neutralize SARS coronavirus (SARS-CoV) infection in Vero E6 cells and in animal models. These...
6.
Blumenstein I, Bock H, Weber C, Rambow A, Tacke W, Kihn R, et al.
Inflamm Bowel Dis
. 2007 Nov;
14(1):53-60.
PMID: 17973301
Background: Studies examining the treatment reality of IBD patients in Germany have been limited, as networking among deliverers of care and reliable documentation of medical, demographic, and economic data are...
7.
Schroder O, Naumann M, Shastri Y, Povse N, Stein J
Aliment Pharmacol Ther
. 2007 Sep;
26(7):1035-42.
PMID: 17877510
Background: Differentiating symptoms of irritable bowel syndrome from those of organic intestinal disease is a common clinical problem. Several neutrophil-derived proteins have been proposed as a marker of inflammatory bowel...
8.
Schroder O, Gerhard R, Stein J
Z Gastroenterol
. 2006 Feb;
44(2):193-204.
PMID: 16456762
The incidence of antibiotic-associated diarrhea (AAD) differs with the antibiotic and varies from 15 - 25 %. Most cases of AAD are directly or indirectly caused by alterations of gut...
9.
Schroder O, Sjostrom M, Qiu H, Jakobsson P, Haeggstrom J
Cell Mol Life Sci
. 2004 Dec;
62(1):87-94.
PMID: 15619010
Cysteinyl-leukotrienes (cys-LTs) are potent smooth muscle contracting agents, which play key roles in inflammatory and allergic diseases. The committed step in cys-LT biosynthesis is catalyzed by leukotriene C(4) synthase (LTC4S)...
10.
Hoepffner N, Schroder O, Stein J
Z Gastroenterol
. 2004 Dec;
42(12):1393-8.
PMID: 15592964
Despite the benefits and the widespread use of enteral and tube feeding (ETF) some patients experience complications, which can be divided in three categories: mechanical, e. g., tube blockage or...